Quick Read Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% toward the deal price. Danaher stock fell 6.09% on integration concerns. Masimo posted Q3 non-GAAP EPS of $1.32, up 38% year-over-year after selling its consumer audio division. A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here. Danaher (NYSE: DHR) is acquiring Masimo (N ...

Group 1 - Danaher announced the acquisition of Masimo for $9.9 billion, expanding its presence in the patient monitoring equipment sector, with a valuation of $180 per share, representing a 38.3% premium over Masimo's previous closing price [1] - Danaher, valued at $150 billion, is primarily focused on drug development and testing tools, marking this acquisition as a new venture outside its core business [1] - Masimo specializes in non-invasive monitoring devices for hospitals, including pulse oximeters and brain activity monitors, and has been in the spotlight due to patent disputes with Apple [1] Group 2 - The acquisition will enhance Danaher's diagnostic product matrix by integrating Masimo's non-invasive monitoring devices with its existing invasive Radiometer blood analysis product line [2] - Danaher expects an increase in adjusted diluted earnings per share by $0.15 to $0.20 in the first full fiscal year post-acquisition, and approximately $0.70 by the fifth full fiscal year, with the deal anticipated to close in the second half of 2026 [2] - The transaction is expected to generate over $125 million in annual cost synergies [2]

Box Office Performance - The 2026 Spring Festival box office exceeded 1.6 billion, with "Flying Life 3," "Silent Awakening," and "Boon Year" ranking as the top three films [2] - On the first day of the Lunar New Year, over 569,000 screenings were held, setting a new record for single-day screenings in history [2][3] Financing and Valuation - Kimi completed over $1.2 billion in financing, with a valuation doubling to over $10 billion [2] - The latest financing round was led by existing shareholders including Alibaba and Tencent, indicating strong investor confidence in Kimi's growth potential [2] AI Shopping and Engagement - Over 130 million people experienced AI shopping for the first time during the Spring Festival, with AI ticket orders increasing by 372 times [2] - Doubao, an AI assistant, achieved 1.9 billion interactions on New Year's Eve, surpassing competitors in app store rankings [2] Company Financials - iFlytek reported operating receipts exceeding 27 billion, with cash flow reaching a record high of 3 billion, marking a 28% year-on-year increase [6] - The gross profit of its open platform model increased by 244%, with a user base of over 100 million for its AI marketing overseas [6] Robotics and Technology Developments - Yushun Technology aims to deliver 10,000 humanoid robots this year, showcasing advancements in autonomous control technology [8] - The Spring Festival featured a high concentration of robots, highlighting the development of China's robotics industry [8] Market Trends and Predictions - Tesla's Cybercab is set to begin production in April 2026, reflecting the company's commitment to innovative transportation solutions [15] - Apple is accelerating the development of three new wearable devices, including AI-driven smart glasses, as part of its strategy to integrate AI into hardware [16] IPO Activity - A total of 143 companies have submitted IPO applications in Hong Kong this year, with expectations for a robust market ahead [16]

Market Overview - The U.S. stock market opened with mixed results, with the Nasdaq down 0.67%, the S&P 500 down 0.27%, and the Dow Jones up 0.13% [1] Technology Sector - Major tech stocks opened lower, with Tesla and Intel both down over 2%, Google A down 1.7%, and Nvidia nearly down 1% [1] Media and Entertainment - Paramount Global's stock rose by 3.5%, while Warner Bros. Discovery increased by 3% after Paramount raised its acquisition offer to $31 per share, prompting Warner to restart a seven-day negotiation window [1] Consumer Goods - General Mills' stock fell by 4.1% as the company lowered its annual sales and profit forecasts, with restructuring costs soaring to $165 million [1] Healthcare Sector - Danaher Corporation's stock dropped nearly 5% after announcing it would acquire Masimo for $180 per share in cash [1]

格隆汇2月17日｜医疗设备制造商美敦力公布2026财年第三季度业绩，营收同比增长8.7%至90亿美元， 超出市场预期1.1亿美元；调整后每股收益为1.36美元，超出市场预期0.02美元。公司重申其2026财年有 机营收增长预期约为5.5%，调整后每股收益预期为5.62美元至5.66美元，低于市场普遍预期的6.12美 元。 来源：格隆汇APP ...

据英国金融时报援引未具名知情人士消息，美国医疗设备制造商丹纳赫即将达成一项近100 亿美元的交 易，收购医疗科技公司迈心诺。若不出现最后时刻意外，收购协议最早可能于周二宣布。丹纳赫与迈心 诺均未立即回应媒体置评请求。 ...

责任编辑：王永生 责任编辑：王永生 据英国金融时报援引未具名知情人士消息，美国医疗设备制造商丹纳赫（Danaher）即将达成一项近100 亿美元的交易，收购医疗科技公司迈心诺（Masimo）。若不出现最后时刻意外，收购协议最早可能于 周二宣布。丹纳赫与迈心诺均未立即回应媒体置评请求。 据英国金融时报援引未具名知情人士消息，美国医疗设备制造商丹纳赫（Danaher）即将达成一项近100 亿美元的交易，收购医疗科技公司迈心诺（Masimo）。若不出现最后时刻意外，收购协议最早可能于 周二宣布。丹纳赫与迈心诺均未立即回应媒体置评请求。 ...

Group 1 - The core announcement is regarding the procurement of disinfection equipment for the 419 Hospital by Tongfang Co., Ltd, with the public notice released on February 13, 2026 [1][3] - Tongfang Co., Ltd has made investments in 48 companies and participated in 19,132 bidding projects [1] - The company holds 543 trademark registrations, 537 patents, and 398 copyrights, along with 37 administrative licenses [1] Group 2 - The supplier for the procurement is Haijin Medical Health Technology (Shaoguan) Co., Ltd [3] - The procurement is specifically for disinfection equipment intended for hospital use [1] - The procurement is taking place in Guangdong Province [3]

Core Viewpoint - The surge in China's gold imports from Russia, projected to increase by 800% to 25.3 tons by 2025, signals a significant shift in the global financial landscape, challenging the dominance of the US dollar and highlighting the growing reliance on gold as a stable asset amidst geopolitical tensions [1][27]. Group 1: Gold Trade Dynamics - The flow of gold between nations is not merely a trade adjustment but a strategic response to financial sanctions, particularly against Russia, which has faced asset freezes and restrictions on the SWIFT system [3][5]. - Russia is leveraging its gold reserves to exchange for essential industrial components from China, effectively bypassing traditional financial systems and sanctions [5][7]. Group 2: Central Bank Behavior - Global central banks have collectively increased their gold holdings, surpassing a total value of $4 trillion, which now exceeds their holdings of US Treasury bonds for the first time in history [10][12]. - Countries like Poland, Kazakhstan, and Turkey have significantly increased their gold reserves, indicating a broader trend of nations diversifying away from US debt [12][14]. Group 3: Market Implications - The price of gold is expected to rise dramatically, potentially exceeding $4,500 to $5,000, as confidence in fiat currencies, particularly the US dollar, declines [16][27]. - The shift from a dollar-centric financial system to one that incorporates gold and the Chinese yuan reflects a fundamental change in global economic dynamics, moving towards a more multipolar system [18][20]. Group 4: New Economic Framework - A new economic triangle is emerging, with Russia and the Middle East providing resources, China offering manufacturing capabilities, and gold serving as a stabilizing asset in transactions [20][21]. - This new framework allows for a more resilient trade system that is less susceptible to unilateral sanctions or financial manipulation by any single nation [23][25].

Core Viewpoint - The world's first 5G brain-heart vehicle, equipped with over 10 patented technologies, aims to provide mobile brain health services and early screening for Alzheimer's disease, addressing the growing concern of dementia in an aging society [1][2]. Group 1: Vehicle and Technology - The 5G brain-heart vehicle can conduct a quick Alzheimer's test in about 15 minutes, with results available in as little as 3 minutes [2][3]. - The vehicle features a flexible brain-machine interface system that allows for rapid screening not only for Alzheimer's but also for other conditions like depression through interchangeable modules [3]. - The vehicle is designed to enhance screening efficiency, potentially doubling the rate of early detection and treatment for Alzheimer's disease [3]. Group 2: Blood Testing Innovation - The vehicle includes a mini-laboratory for blood testing, which can accurately detect Alzheimer's disease using a single blood sample, a method that is more accessible than traditional PET-CT scans or lumbar punctures [4]. - This blood plasma biomarker test has a sensitivity and specificity exceeding 90% and can predict Alzheimer's risk 10-15 years in advance [4]. Group 3: Future Upgrades and Expansion - Future upgrades for the 5G brain-heart vehicle will focus on three areas: real-time data transmission and AI-assisted diagnosis, creating a closed-loop service model with family doctors, and developing a standardized output model for broader application [6]. - The initiative aims to transform the vehicle into a replicable "Guangdong solution," promoting high-quality medical resources through partnerships and opportunities along the Belt and Road Initiative [6].